Data exclusivity (and market exclusivity) are granted by regulatory authorities, not patent offices, upon drug approval
But it is not the cheapest compounded option available
Primary Research Areas Growth hormone secretion dynamics: Laboratory models exploring synergistic GH release via concurrent activation of GHS-R by Ipamorelin and GHRH receptors by CJC-1295 (no DAC), including studies of GH pulse amplitude and frequency
Incretin-like hormones, such as glucagon-like peptide-1 (GLP-1), exert their effects by inducing glucose-dependent effects on insulin secretion, inhibiting glucagon release, slowing gastric emptying, and reducing food intake, ultimately leading to weight loss [5, 6]
"The question is, what other animal has something to teach us that can be of future value